We are live on ! Find out more
HCA

Harbor Capital Advisors Portfolio holdings

AUM $1.47B
1-Year Est. Return 42.58%
This Fund
S&P 500
This Quarter Est. Return
+12.08%
1 Year Est. Return
+42.58%
3 Year Est. Return
+118.91%
5 Year Est. Return
10 Year Est. Return
AUM
$765M
AUM Growth
+$245M
Cap. Flow
+$186M
Cap. Flow %
24.35%
Top 10 Hldgs %
18.2%
Holding
888
New
450
Increased
153
Reduced
141
Closed
144

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$14.1M
2
JPM icon
JPMorgan Chase
JPM
+$10.5M
3
CAT icon
Caterpillar
CAT
+$3.36M
4
KO icon
Coca-Cola
KO
+$3.22M
5
PEP icon
PepsiCo
PEP
+$3.2M

Sector Composition

Rank Sector Weight
1 Technology 26.33%
2 Healthcare 14.95%
3 Financials 12.18%
4 Consumer Discretionary 11.72%
5 Industrials 10.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AL
201
DELISTED
Air Lease Corp
AL
$1.03M 0.14%
+20,120
New +$860K
LSCC icon
202
Lattice Semiconductor
LSCC
$17.9B
$1.03M 0.13%
13,186
-299
-2% -$21.4K
EW icon
203
Edwards Lifesciences
EW
$54B
$1.03M 0.13%
+10,792
New +$907K
MC icon
204
Moelis & Co
MC
$4.93B
$1.03M 0.13%
+18,120
New +$990K
LHX icon
205
L3Harris
LHX
$53.3B
$1.03M 0.13%
+4,825
New +$1.01M
PRVA icon
206
Privia Health
PRVA
$2.81B
$1.03M 0.13%
+52,464
New +$1.11M
RNAM
207
DELISTED
Avidity Biosciences
RNAM
$1.02M 0.13%
40,068
+7,718
+24% +$121K
FCNCA icon
208
First Citizens BancShares
FCNCA
$25.4B
$1.02M 0.13%
+625
New +$940K
STEP icon
209
StepStone Group
STEP
$4.07B
$1.02M 0.13%
28,579
-5,207
-15% -$176K
TMO icon
210
Thermo Fisher Scientific
TMO
$224B
$1.02M 0.13%
1,752
+397
+29% +$223K
MDB icon
211
MongoDB
MDB
$35.3B
$1.02M 0.13%
2,837
+58
+2% +$23.7K
CMI icon
212
Cummins
CMI
$87.1B
$1.01M 0.13%
3,443
+36
+1% +$9.28K
REZI icon
213
Resideo Technologies
REZI
$3.67B
$1.01M 0.13%
+45,119
New +$891K
TDW icon
214
Tidewater
TDW
$4.54B
$996K 0.13%
+10,825
New +$807K
KLAC icon
215
KLA
KLAC
$262B
$995K 0.13%
+14,250
New +$915K
MRNA icon
216
Moderna
MRNA
$24.2B
$992K 0.13%
9,312
-530
-5% -$53.4K
PTCT icon
217
PTC Therapeutics
PTCT
$6.15B
$991K 0.13%
34,054
-4,329
-11% -$121K
RYTM icon
218
Rhythm Pharmaceuticals
RYTM
$7.77B
$987K 0.13%
+22,781
New +$997K
GTLB icon
219
GitLab
GTLB
$7.11B
$980K 0.13%
16,807
+13,779
+455% +$903K
WING icon
220
Wingstop
WING
$3.03B
$978K 0.13%
+2,669
New +$830K
CWST icon
221
Casella Waste Systems
CWST
$5.89B
$975K 0.13%
+9,862
New +$884K
STLD icon
222
Steel Dynamics
STLD
$37.8B
$970K 0.13%
6,544
+5,211
+391% +$655K
DD icon
223
DuPont de Nemours
DD
$19.5B
$967K 0.13%
10,047
+1,838
+22% +$164K
BHF icon
224
Brighthouse Financial
BHF
$3.38B
$962K 0.13%
18,669
-19,637
-51% -$975K
SPG icon
225
Simon Property Group
SPG
$71.2B
$962K 0.13%
+6,147
New +$901K

Similar funds

Harbor Capital Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Harbor Capital Advisors held 888 positions worth $765M, up 47% from $520M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Harbor Capital Advisors deployed $186M of net new capital in Q1 2024, opening 450 new positions and adding to 153 existing holdings. Its largest new stake was JPMorgan Chase: 58,173 shares worth $11.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Merck, an estimated $5.12M trimmed.

  • Harbor Capital Advisors's largest Q1 2024 buy was JPMorgan Chase: 58,173 shares worth $11.7M.
  • Harbor Capital Advisors added most to Amazon in Q1 2024, an estimated $14.1M increase.
  • Harbor Capital Advisors's biggest Q1 2024 reduction was Merck, cutting an estimated $5.12M.
  • Harbor Capital Advisors fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2024, selling an estimated $17M.
  • Harbor Capital Advisors's ten largest holdings make up 18% of its $765M portfolio in Q1 2024.
  • Harbor Capital Advisors opened 450 new positions and closed 144 in Q1 2024.
  • Harbor Capital Advisors's portfolio value rose 47% quarter-over-quarter to $765M.

Based on Harbor Capital Advisors's 13F filing for Q1 2024, filed 13 May 2024.